According to a DigiTimes Asia report, Apple Watch sales in the first half of 2025 exceeded expectations by 10%. The report also highlights the upcoming 2026 Apple Watch lineup, which will bring three notable changes: double the number of sensor components, exterior design alterations, and improved power efficiency. The lineup may also feature a blood pressure detection feature, although non-invasive blood glucose monitoring remains uncertain due to medical regulations and patent disputes.
Apple Watch sales in the first half of 2025 exceeded expectations by 10%, according to a report by DigiTimes Asia [2]. This strong performance comes despite challenges from tariffs and macroeconomic factors. The report also provides insights into the upcoming 2026 lineup, which promises significant advancements.
The 2026 Apple Watch lineup is set to introduce three notable changes: double the number of sensor components, exterior design alterations, and improved power efficiency [2]. Additionally, there are indications that the lineup may feature a blood pressure detection feature, although non-invasive blood glucose monitoring remains uncertain due to medical regulations and patent disputes [2].
The report also mentions that Apple Watch Series 9, Series 10, and Ultra 2 users in the U.S. will have access to the redesigned Blood Oxygen feature after updating their paired iPhone to iOS 18.6.1 and their Apple Watch to watchOS 11.6.1 [3]. This update was enabled by a recent U.S. Customs ruling.
These developments suggest that Apple is committed to enhancing its wearable technology, potentially driving further growth in the market. Investors and financial professionals should keep an eye on these advancements as they may influence Apple's stock performance.
References:
[1] https://finance.yahoo.com/news/jim-cramer-defends-apple-inc-183215916.html
[2] https://9to5mac.com/2025/08/15/report-2026-apple-watch-lineup-will-bring-three-notable-changes/
[3] https://www.macworld.com/article/2878472/the-apple-watch-blood-oxygen-sensor-is-coming-back-to-series-9-10-and-ultra-2-users.html
Comments
No comments yet